Results 151 to 159 of about 22,047 (159)

A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation

JACC: Clinical Electrophysiology, 2018
, , Christopher P Cannon
exaly  

Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement

Journal of Bone and Joint Surgery: British Volume, 2012
M R Lassen
exaly  

Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease

Journal of Stroke and Cerebrovascular Diseases, 2012
John W Eikelboom, Peggy Gao, Raffaele De Caterina   +2 more
exaly  

Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects

American Journal of Cardiovascular Drugs, 2013
Jessie Wang, Donglu Zhang, Rebecca A Boyd   +2 more
exaly  

Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis

International Journal of Cardiology, 2013
Anne-Céline Martin, Bernard F Le Bonniec, Anne-Marie Fischer   +2 more
exaly  

Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor

European Journal of Drug Metabolism and Pharmacokinetics, 2011
Kan He, Joseph M Luettgen, Donglu Zhang   +2 more
exaly  

Metabolism, pharmacokinetics and pharmacodynamics of the factor Xa inhibitor apixaban in rabbits

Journal of Thrombosis and Thrombolysis, 2009
Donglu Zhang, Kan He, Earl J Crain
exaly  

Apixaban: A Review of its Use for Reducing the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

Drugs, 2013
exaly  

Apixaban

Reactions Weekly, 2017
openaire   +1 more source